SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Gentex Corporation (GNTX) trades at a trailing P/E of 12.5, forward P/E of 11.3. Trailing earnings yield is 7.97%, forward earnings yield 8.87%. PEG 0.96 (Peter Lynch undervalued ≤1.0). Graham Number is $21.16.
Criteria proven by this page:
- VALUE (66/100, Pass) — P/E is below market average (12.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.96); analyst target implies upside (+18.5%); earnings yield beats bond yields (7.97%).
- Forward P/E 11.3 (down from trailing 12.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.96 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 7.97% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 8.87% as earnings recover.
- Analyst consensus target $26.00 (+18.5% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 75/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
66/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GNTX
Valuation Multiples
P/E (TTM)12.5
Forward P/E11.3
PEG Ratio0.96
Forward PEG0.96
P/B Ratio1.94
P/S Ratio1.90
EV/EBITDA8.5
Per Share Data
EPS (TTM)$1.75
Forward EPS (Est.)$1.95
Book Value / Share$11.35
Revenue / Share$11.55
FCF / Share$2.09
Yields & Fair Value
Earnings Yield7.97%
Forward Earnings Yield8.87%
Dividend Yield2.18%
Graham Number$21.16
SharesGrow IV$59.56 (+171.3%)
Analyst Target$26.00 (+18.5%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
16.3 |
1.48 |
2.97 |
3.38 |
1.78% |
| 2017 |
14.7 |
0.85 |
2.92 |
3.34 |
1.82% |
| 2018 |
12.4 |
0.80 |
2.91 |
2.95 |
2.15% |
| 2019 |
17.2 |
9.39 |
3.76 |
3.93 |
1.59% |
| 2020 |
23.7 |
-1.52 |
4.19 |
4.88 |
1.42% |
| 2021 |
22.7 |
3.21 |
4.24 |
4.74 |
1.40% |
| 2022 |
19.7 |
-1.99 |
3.05 |
3.28 |
1.80% |
| 2023 |
17.5 |
0.50 |
3.24 |
3.26 |
1.50% |
| 2024 |
16.0 |
-4.21 |
2.63 |
2.80 |
1.70% |
| 2025 |
13.3 |
-7.83 |
2.05 |
2.02 |
2.09% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.19 |
$1.68B |
$347.59M |
20.7% |
| 2017 |
$1.41 |
$1.79B |
$406.79M |
22.7% |
| 2018 |
$1.62 |
$1.83B |
$437.88M |
23.9% |
| 2019 |
$1.66 |
$1.86B |
$424.68M |
22.8% |
| 2020 |
$1.41 |
$1.69B |
$347.56M |
20.6% |
| 2021 |
$1.50 |
$1.73B |
$360.8M |
20.8% |
| 2022 |
$1.36 |
$1.92B |
$318.76M |
16.6% |
| 2023 |
$1.84 |
$2.3B |
$428.4M |
18.6% |
| 2024 |
$1.76 |
$2.31B |
$404.49M |
17.5% |
| 2025 |
$1.74 |
$2.53B |
$384.84M |
15.2% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.94 |
$1.90 – $2.02 |
$2.65B |
$2.62B – $2.66B |
5 |
| 2027 |
$2.15 |
$2.04 – $2.32 |
$2.77B |
$2.76B – $2.79B |
5 |
| 2028 |
$2.43 |
$2.32 – $2.64 |
$2.9B |
$2.89B – $2.91B |
4 |
| 2029 |
$2.62 |
$2.58 – $2.64 |
$3.01B |
$2.97B – $3.02B |
2 |
| 2030 |
$2.88 |
$2.84 – $2.90 |
$3.1B |
$3.07B – $3.12B |
2 |
